Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Name: Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
License: Public Domain

Melanoma Institute Australia

ClinicalTrials.gov · Datasets · License: Public Domain

merkel cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 394588
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.